Literature DB >> 419982

Prevalence of pinguecula in Greenland and in Copenhagen, and its relation to pterygium and spheroid degeneration.

M S Norn.   

Abstract

The prevalence of pinguecula has been studied by slit lamp examination of 659 Eskimos in South Greenland and 810 Caucasians in Copenhagen. The overall prevalence was found to be 56 per cent in Greenland against 41 per cent in Copenhagen (P less than 0.001) and to rise with increasing age, though with a fall after the age of 60 among Greenland women. Pingueculae (measured by their vertical height) are largest among Greenlanders, and larger in males than in females. They increase in size with increasing age. They are generally located nasally in Greenlanders and temporally in Copenhageners. The prevalence of pinguecula in almost 1 1/2 times higher among Greenlanders than among Copenhageners, while that of spheroid degeneration and that of pterygium are 3 times and slightly over 10 times higher respectively. The incidence of pinguecula and spheroid degeneration are correlated per site and per subject in the two geographically different series. Pterygium is not correlated with regard to site, this being always located nasally. Pterygium practically never harbours spheroid degeneration, neither in its body nor in its head (81 pterygia). Pinguecula and pterygium are therefore to be regarded as two different disorders, while spheroid degeneration is related to pinguecula.

Entities:  

Mesh:

Year:  1979        PMID: 419982     DOI: 10.1111/j.1755-3768.1979.tb06664.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  14 in total

1.  Pterygium in Indonesia: prevalence, severity and risk factors.

Authors:  G Gazzard; S-M Saw; M Farook; D Koh; D Widjaja; S-E Chia; C-Y Hong; D T H Tan
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

Review 2.  [Epidemiology of pterygium. A review].

Authors:  K Droutsas; W Sekundo
Journal:  Ophthalmologe       Date:  2010-06       Impact factor: 1.059

3.  Prevalence of pinguecula and pterygium in a general population in Spain.

Authors:  E Viso; F Gude; M T Rodríguez-Ares
Journal:  Eye (Lond)       Date:  2010-12-24       Impact factor: 3.775

4.  Human papillomavirus and pterygium. Is the virus a risk factor?

Authors:  Nicolai Christian Sjö; Christian von Buchwald; Jan Ulrik Prause; Bodil Norrild; Troels Vinding; Steffen Heegaard
Journal:  Br J Ophthalmol       Date:  2006-12-19       Impact factor: 4.638

5.  Prevalence and racial differences in pterygium: a cross-sectional study in Han and Uygur adults in Xinjiang, China.

Authors:  Ting Chen; Lin Ding; Guangliang Shan; Limujiang Ke; Jin Ma; Yong Zhong
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-01-27       Impact factor: 4.799

Review 6.  Pterygium as an early indicator of ultraviolet insolation: a hypothesis.

Authors:  M T Coroneo
Journal:  Br J Ophthalmol       Date:  1993-11       Impact factor: 4.638

7.  Risk Factors for Pterygium in Ilam Province, Iran.

Authors:  Parviz Malekifar; Hamed Esfandiari; Nazanin Behnaz; Fatemeh Javadi; Sima Azish; Mohammad Ali Javadi; Masumeh Kalantarion
Journal:  J Ophthalmic Vis Res       Date:  2017 Jul-Sep

8.  Relationship between pinguecula formation and exposure to tandoor ovens in a hospital-based study.

Authors:  Adem Gul; Hasan Goker; Senol Sabanci; Ali Kurt; Kemal Turkyilmaz
Journal:  Int J Ophthalmol       Date:  2014-12-18       Impact factor: 1.779

9.  Prevalence, treatment, and outcomes of coexistent ocular surface squamous neoplasia and pterygium.

Authors:  Patrick Oellers; Carol L Karp; Anoop Sheth; Andrew A Kao; Amany Abdelaziz; Jared L Matthews; Sander R Dubovy; Anat Galor
Journal:  Ophthalmology       Date:  2012-10-27       Impact factor: 12.079

10.  Prevalence and associated factors for pterygium in rural agrarian central India. The central India eye and medical study.

Authors:  Vinay Nangia; Jost B Jonas; Deepa Nair; Nandita Saini; Prabhat Nangia; Songhomitra Panda-Jonas
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.